397 related articles for article (PubMed ID: 22777936)
1. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
Rossignol P; Cridlig J; Lehert P; Kessler M; Zannad F
Hypertension; 2012 Aug; 60(2):339-46. PubMed ID: 22777936
[TBL] [Abstract][Full Text] [Related]
2. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
Zannad F; Kessler M; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P
Kidney Int; 2006 Oct; 70(7):1318-24. PubMed ID: 16871247
[TBL] [Abstract][Full Text] [Related]
4. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
Kessler M; Zannad F; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P;
Nephrol Dial Transplant; 2007 Dec; 22(12):3573-9. PubMed ID: 17611249
[TBL] [Abstract][Full Text] [Related]
5. Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study.
Rossignol P; Girerd N; Gregory D; Massaro J; Konstam MA; Zannad F
Int J Cardiol; 2015; 187():183-9. PubMed ID: 25828348
[TBL] [Abstract][Full Text] [Related]
6. Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy).
Arashi H; Ogawa H; Yamaguchi J; Kawada-Watanabe E; Hagiwara N
Am J Cardiol; 2015 Jul; 116(2):236-42. PubMed ID: 25966826
[TBL] [Abstract][Full Text] [Related]
7. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients.
Sarafidis PA; Loutradis C; Karpetas A; Tzanis G; Piperidou A; Koutroumpas G; Raptis V; Syrgkanis C; Liakopoulos V; Efstratiadis G; London G; Zoccali C
Hypertension; 2017 Jul; 70(1):148-157. PubMed ID: 28483919
[TBL] [Abstract][Full Text] [Related]
9. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
Mancia G; Facchetti R; Parati G; Zanchetti A
Circulation; 2012 Jul; 126(5):569-78. PubMed ID: 22761453
[TBL] [Abstract][Full Text] [Related]
10. FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics.
Zannad F; Kessler M; Grünfeld JP; Thuilliez C;
Fundam Clin Pharmacol; 2002 Oct; 16(5):353-60. PubMed ID: 12602460
[TBL] [Abstract][Full Text] [Related]
11. [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].
Tasić IS; Mijalković D; Djordjević D; Lović B; Janković D; Miladinović-Tasić N; Lović M
Srp Arh Celok Lek; 2006; 134(3-4):106-13. PubMed ID: 16915750
[TBL] [Abstract][Full Text] [Related]
12. Influence of renin angiotensin system gene polymorphisms on visit-to-visit blood pressure variability in hypertensive patients.
Kawai T; Ohishi M; Onishi M; Takeya Y; Ito N; Kato N; Yamamoto K; Kamide K; Rakugi H
Am J Hypertens; 2012 Dec; 25(12):1249-55. PubMed ID: 22932704
[TBL] [Abstract][Full Text] [Related]
13. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
[TBL] [Abstract][Full Text] [Related]
14. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.
Chang TI; Tabada GH; Yang J; Tan TC; Go AS
J Hypertens; 2016 Feb; 34(2):244-52. PubMed ID: 26599220
[TBL] [Abstract][Full Text] [Related]
15. Relationship between different blood pressure measurements and left ventricular mass by cardiac magnetic resonance imaging in end-stage renal disease.
Merchant A; Wald R; Goldstein MB; Yuen D; Kirpalani A; Dacouris N; Ray JG; Kiaii M; Leipsic J; Kotha V; Deva D; Yan AT
J Am Soc Hypertens; 2015 Apr; 9(4):275-84. PubMed ID: 25753299
[TBL] [Abstract][Full Text] [Related]
16. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994.
Muntner P; Shimbo D; Tonelli M; Reynolds K; Arnett DK; Oparil S
Hypertension; 2011 Feb; 57(2):160-6. PubMed ID: 21200000
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Chan YH; Hai JSH; Lau KK; Tse HF
Cardiovasc Diabetol; 2021 Apr; 20(1):88. PubMed ID: 33894788
[TBL] [Abstract][Full Text] [Related]
18. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.
Rossignol P; Kessler M; Zannad F
Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):59-64. PubMed ID: 23165110
[TBL] [Abstract][Full Text] [Related]
19. Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: the Ambulatory Blood Pressure-International Study.
Palatini P; Reboldi G; Beilin LJ; Casiglia E; Eguchi K; Imai Y; Kario K; Ohkubo T; Pierdomenico SD; Schwartz JE; Wing L; Verdecchia P
Hypertension; 2014 Sep; 64(3):487-93. PubMed ID: 24935939
[TBL] [Abstract][Full Text] [Related]
20. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population.
Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; de Leeuw PW; Jaaskivi M; Nachev C; Parati G; O'Brien ET; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH;
J Hypertens; 2003 Dec; 21(12):2251-7. PubMed ID: 14654744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
